NCT00569959 Assessment of Non-Fasting vs. Fasting Lipid Measures in Diabetes Patients Status COMPLETED Phase NA
NCT00565162 Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus Status COMPLETED Phase PHASE4
NCT00562952 Nt-proBNP Guided Primary Prevention of CV Events in Diabetic Patients Status COMPLETED Phase PHASE2/PHASE3
NCT00562133 Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00554671 Pharmacist-led Group Medical Visits to Help With Diabetes Management Status COMPLETED Phase NA
NCT00552994 Comparison of Coronary Xience V and the Cypher Select+ Stents in Diabetic Patients Status COMPLETED Phase NA
NCT00552409 Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00552227 Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT00547872 Exercise Testing to Screen for Unknown Coronary Artery Disease in Diabetic Patients: Does it Contribute to a Risk Reduction in Very High Risk Patients? Status COMPLETED Phase PHASE3
NCT00542204 Use of Online Personalized Health Record System to Promote Self-Management of Diabetes Status COMPLETED Phase NA
NCT00536965 Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets Status COMPLETED Phase N/A
NCT00536796 Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets Status COMPLETED Phase N/A